Publication: Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma
Issued Date
2013-09-01
Resource Type
ISSN
18788769
18788750
18788750
Other identifier(s)
2-s2.0-84885182640
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
World Neurosurgery. Vol.80, No.3-4 (2013), 359-363
Suggested Citation
Melanie G. Hayden Gephart, Ake Hansasuta, Raymond R. Balise, Clara Choi, Gordon T. Sakamoto, Andrew S. Venteicher, Scott G. Soltys, Iris C. Gibbs, Griffith R. Harsh, John R. Adler, Steven D. Chang Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma. World Neurosurgery. Vol.80, No.3-4 (2013), 359-363. doi:10.1016/j.wneu.2012.04.001 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/32183
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma
Abstract
Objective: For multisession radiosurgery, no published data relate the volume and dose of cochlear irradiation to quantified risk of hearing loss. We conducted a retrospective, dosimetric study to evaluate the relationship between hearing loss after stereotactic radiosurgery (SRS) and the dose-volume of irradiated cochlea. Methods: Cochlear dose data were retrospectively collected on consecutive patients who underwent SRS (18 Gy in 3 sessions) for vestibular schwanoma between 1999 and 2005 at Stanford University Hospital. Inclusion criteria included Gardner-Robertson (GR) grade I or II hearing prior to radiosurgical treatment, complete audiograms, and magnetic resonance imaging (MRI) follow-up. A cochlea dose-volume histogram was generated for each of the 94 patients who qualified for this study. Results: GR grade I-II hearing posttreatment was maintained in 74% of patients (70/94). Median time to last follow-up audiogram was 2.4 years (range 0.4-8.9) and to last MRI was 3.6 years (range 0.5-9.4). Each higher level of cochlear irradiation was associated with increased risk of hearing loss. Larger cochlear volume was associated with lower risk of hearing loss. Controlling for differences in cochlear volume among subjects, each additional mm3of cochlea receiving 10 to 16 Gy (single session equivalent doses of 6.6-10.1 Gy3) significantly increased the odds of hearing loss by approximately 5%. Conclusions: Larger cochlear volume is associated with lower risk of hearing loss following trisession SRS for vestibular schwannoma. Controlling for this phenomenon, higher radiation dose and larger irradiated cochlear volume are significantly associated with higher risk of hearing loss. This study confirms and quantifies the risk of hearing loss following trisession SRS for vestibular schwannoma. © 2013 Elsevier Inc. All rights reserved.